ECO 2009 -- The 17th European Congress ...( The 17th European Congress on Obesit...),Health
The 17th European Congress on Obesity (ECO) will take place at the RAI Exhibition and Congress Centre in Amsterdam, the Netherlands (http://www.rai.nl/Contactformulier.aspx) from Wednesday 6 May to Saturday 9 May 2009.
Excess body weight is a major risk factor for several chronic diseases, including diabetes, heart disease, stroke and cancer, making obesity one of the leading preventable causes of death worldwide. With global rates in adults and children on the rise, the condition is considered one of the most significant public health challenges of the 21st century.
ECO 2009 provides a unique European forum for presentations of exciting new research from scientists, clinicians, epidemiologists and public health specialists. About 2,500 scientists, doctors, nurses and public health policy experts are expected to attend.
The European Association for the Study of Obesity welcomes the interest of the media in obesity issues and is happy to provide full assistance to journalists attending ECO 2009. A media centre with computing, fax, photocopying and free international phone and Internet connections will be available. English-speaking press officers will be on hand to assist you.
NB: the official language of ECO 2009 is English and all press materials will be in English.
Media Registration
ECO 2009 is open to bona fide representatives of print and electronic media. Registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication and may be asked to provide sample copies of the publication.
The media registration form (which can be downloaded from the ECO 2009 website at http://www.easo.org/eco2009/press.htm should be sent, a
'/>"/>
| Contact: Emma Ross rosswrite@mac.com 44-207-193-4349 European Association for the Study of Obesity Source:Eurekalert |
Related medicine news :
1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. Launch of second European Cancer Research Funding survey
7. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
8. Pharsight to Host European Software Conference
9. OmniGuide Begins European Commercialization
10. Paving the way for future pan-European clinical trials
11. US, European cancer educators gather in Alabama for meeting
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |